2022
DOI: 10.1182/blood-2022-170301
|View full text |Cite
|
Sign up to set email alerts
|

Utilization of Pharmacogenomics in Assessment of Tolerability and Efficacy of BTK Inhibitors

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles